Hikal Limited Financial Ratios
HIKAL · Healthcare · Current price ₹216
P/E ratio
-85.8x
P/B ratio
2.4x
ROE
-4.1%
ROCE
-0.9%
Debt / Equity
0.57
Dividend yield
0.3%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | -85.8x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 2.4x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -4.1% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | -0.9% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.57 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Hikal Limited's latest numbers.
Hikal Limited profitability
Hikal Limited generates a return on equity of -4.1% and a return on capital employed of -0.9%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.57 and a P/E of -85.8x, Hikal Limited is moderately leveraged. Our overall business-quality score for the company is 3.2 / 10.
Understand the ratios
More on Hikal Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.